Zusammenfassung
ICD-10-Code T86.05+H58.1*, T86.06+H58.21* bzw. H58.22*, T86.07+H58.23*
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Abud TB, Amparo F, Saboo US et al (2016) A clinical trial comparing the safety and efficacy of topical tacrolimus versus methylprednisolone in ocular graft-versus-host disease. Opthalmology 123:1449–1457
Anderson GA, Regillo C (2004) Ocular manifestations of graft versus host disease. Curr Opin Ophthalmol 15:503–507
Azari AA, Karadag R, Kanavi MR et al (2017) Safety and efficacy of autologous serum eye drop for treatment of dry eyes in graft-versus-host disease. Cutan Ocul Toxicol 36:152–156
Baird K, Pavletic SZ (2006) Chronic graft versus host disease. Curr Opin Hematol 13:426–435
Blecha C, Angstwurm K, Wolff D et al (2015) Retinal involvement in a patient with cerebral manifestation of chronic graft- versus-host disease. Oncol Res Treat 38:532–534
Blecha C, Wolff D, Holler B et al (2016) Verification of the new grading scale for ocular chronic graft-versus-host disease developed by the German-Austrian-Swiss consensus conference on chronic GVHD. Ann Hematol 95:493–499
Boynton GE, Raoof D, Niziol LM et al (2015) Prospective randomized trial comparing efficacy of topical loteprednol etabonate 0,5 % versus cyclosporine A 0,05 % for treatment of dry eye syndrome following hematopoetic stem cell transplantation. Cornea 34:725–732
Busin M, Giannacare G, Sapigni L et al (2017) Conjunctival and limbal transplantation from the same living-related bone marrow donor to patients with severe ocular graft-vs-host disease. JAMA Oplthalmol 135:1123–1125
Couriel D, Carpenter PA, Cutler C et al (2006) Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report. Biol Blood Marrow Transplant 12:375–396
Dastjerdi MH, Hamrah P, Dana R (2009) High-frequency topical cyclosporine 0.05 % in the treatment of severe dry eye refractory to twice-daily regimen. Cornea 28:1091–1096
Dietrich-Ntoukas T, Cursiefen C, Westekemper H et al (2012) Diagnosis and treatment of ocular chronic graft-versus-host disease: report from the German-Austrian-Swiss Consensus Conference on Clinical Practice in Chronic GVHD. Cornea 31:299–310
Ferrara JL, Deeg HJ (1991) Graft-versus-host disease. N Engl J Med 324:667–674
Ferrara JL, Levine JE, Reddy P, Holler E (2009) Graft-versus-host disease. Lancet 373:1550–1561
Filipovich AH (2008) Diagnosis and manifestations of chronic graft-versus-host disease. Best Pract Res Clin Haematol 21:251–257
Filipovich AH, Weisdorf D, Pavletic S et al (2005) National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 11:945–956
Giannacare G, Pellegrini M, Bernabei et al (2019) Ocular surface system alterations in ocular graft-versus-host disease: allpieces of the complex puzzle. Graefes Arch Clin Exp Ophthalmol 275:1341–1351
Hessen M, Akpek EK (2012) Ocular graft-versus-host disease. Curr Opin Allergy Clin Immunol 12:540–547
Jagasia MH, Greinix HT, Arora M et al (2015) National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working Group report. Biol Blood Marrow Transplant 21(3):389–401
Kim SK (2006) Update on ocular graft versus host disease. Curr Opin Ophthalmol 17:344–348
Kim SK, Smith JA, Dunn JP (2009) Chronic Ocular Graft versus Host Disease. In: Vogelsang GB, Pavletic SZ (Hrsg) Chronic graft versus host disease: interdisciplinary management. Cambridge University Press, New York, S S 199–S 206
Lee SJ, Vogelsang G, Flowers ME (2003) Chronic graft-versus-host disease. Biol Blood Marrow Transplant 9:215–233
Magro L, Gauthier J, Richet M et al (2017) Scleral lenses for severe chronic GvHD-related keratoconjunctivitis sicca: a retrospective study by the SFGM-TC. Bone Marrow Transplant 52:878–882
Malta JB, Soong HK, Shtein RM et al (2010) Treatment of ocular graft-versus-host disease with topical cyclosporine 0,05 %. Cornea 29:1392–1396
Matzinger P (2002) The danger model: a renewed sense of self. Science 296:301–305
Meller D, Fuchsluger T, Pauklin M, Steuhl KP (2009) Ocular surface reconstruction in graft-versus-host disease with HLA-identical living-related allogeneic cultivated limbal epithelium after hematopoetic stem cell transplantation from the same donor. Cornea 28:233–236
Ogawa Y, Kuwana M (2003) Dry eye as a major complication associated with chronic graft-versus-host disease after hematopoietic stem cell transplantation. Cornea 22:19–27
Ogawa Y, Shimmura S, Kawakita T et al (2009) Epithelial mesenchymal transition in human ocular chronic graft-versus-host disease. Am J Pathol 175:2372–2381
Ogawa Y, Kim SK, Dana R et al (2013) International chronic ocular graft-versus-host disease (GVHD) consensus group: proposed diagnostic criteria for chronic GVHD (part I). Sci Rep 3:3419
Pavletic SZ, Vogelsang GB, Lee SJ (2015) 2014 National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: preface to the series. Biol Blood Marrow Transpl 21:387–388
Peric Z, Skegro I, Durakovic N et al (2018) Amniotic membrane transplantation – a new approach to crossing the HLA barriers in the treatment of refractory ocular graft-versus-host disease. One Marrow Transplantat 53:1466–1469
Robinson MR, Lee SS, Rubin BI et al (2004) Topical corticosteroid therapy for cicatricial conjunctivitis associated with chronic graft-versus-host disease. Bone Marrow Transplant 33:1031–1035
Rojas B, Cuhna R, Zafrakis P et al (2005) Cell populations and adhesion molecules expression in conjunctiva before and after bone marrow transplantation. Exp Eye Res 81:313–325
Shlomchik WD (2007) Graft-versus-host disease. Nat Rev Immunol 7:340–352
Tahmaz V, Gehlsen U, Sauerbier L et al (2017) Treatment of severe chronic ocular graft-versus-host disease using 100 % autologous serum eye drops from a sealed manufacturing system: a retrospective cohort study. Br J Ophthalmol 101:322–326
Wang Y, Ogawa Y, Dogru M et al (2008) Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease. Bone Marrow Transplant 41:293–302
Welniak LA, Blaza BR, Murphy WJ (2007) Immunobiology of allogeneic hematopoetic stem cell transplantation. Annu Rev Immunol 25:139–170
Westekemper H, Meller S, Citak S et al (2010) Differential chemokine expression in chronic GVHD of the conjunctiva. Bone Marrow Transplant 45:1340–1346
Wolff D, Gerbitz A, Ayuk F et al (2010) Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): First-line and topical treatment of chronic GVHD. Biol Blood Marrow Transplant 16:1611–1628
Wolff D, Bertz H, Greinix H et al (2011) The treatment of chronic graft-versus-host disease: consensus recommendations of experts from Germany, Austria and Switzerland. Dtsch Ärztebl Int 108:732–740
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature
About this chapter
Cite this chapter
Dietrich-Ntoukas, T. (2021). Graft-versus-host-disease (GVHD) (engl. graft-versus-host disease). In: Pleyer, U. (eds) Entzündliche Augenerkrankungen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-60399-4_13
Download citation
DOI: https://doi.org/10.1007/978-3-662-60399-4_13
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-60398-7
Online ISBN: 978-3-662-60399-4
eBook Packages: Medicine (German Language)